NIPER Raebareli, AstraZeneca partner to expand clinical trials to 25 emerging hubs
New Delhi, Oct 14 (IANS) The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli and AstraZeneca India have collaborated to expand clinical trial capabilities beyond metros to strengthen India's clinical research capabilities and increase the country's participation in global clinical trials, according to an official statement released on Wednesday.